CRISPR Therapeutics AG (NASDAQ:CRSP)

147.29
Delayed Data
As of Dec 04
 +6.83 / +4.86%
Today’s Change
32.30
Today|||52-Week Range
151.11
+141.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
AssetsCash487.3M456.6M437.5M427.9M
 
 
 
 
 
Short Term Investment Cash167.6M-30.6M-19.1M-8.9M
 
 
 
 
 
Cash & Short Term Investments487.3M456.6M437.5M427.9M
 
 
 
 
 
 
ReceivablesReceivables552.0K88.0K331.0K321.0K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses------2.8M
 
 
Other Current Assets8.8M9.7M11.9M7.5M
 
 
 
 
 
Current Assets496.7M466.4M449.8M438.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross24.5M25.9M52.3M60.3M
 
 
 
 
 
Depreciation-6.4M-7.4M-8.3M-9.4M
 
 
 
 
 
Intangible Assets303.0K289.0K276.0K262.0K
 
 
 
 
 
Other Assets953.0K958.0K945.0K931.0K
 
 
 
 
 
Total Assets518.9M489.0M497.9M494.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.2M5.1M7.1M7.1M
 
 
 
 
 
Short Term Debt0.000.004.9M4.9M
 
 
 
Accrued Expenses21.5M14.7M11.8M13.0M
 
 
 
 
 
Other Current Liabilities21.7M15.0M11.9M13.2M
 
 
 
 
 
Other Liabilities32.3M27.7M28.4M31.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt--0.0031.7M37.2M
 
 
 
Other Liabilities11.5M11.3M182.0K220.0K
 
 
 
 
 
Total Liabilities101.6M96.8M118.1M126.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity417.3M392.2M379.8M367.7M
 
 
 
 
 
Total Shareholder Equity417.3M392.2M379.8M367.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding51.6M51.9M52.6M53.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.